Chris Wade Agrees with Gartner a CRM must have KAM Capabilities
Gartner mentions Exeevo for their KAM capabilities and Chris weighs in on why CRMs with Key Account Management capabilities is the path to commercial growth.
Author: Cynthia Ruffino
Chris Wade talks Gartner’s advice on the Veeva Salesforce Break-up
The Veeva Salesforce breakup will affect your business in different ways. So why stand still when there is an option that meets today’s needs and is also future-ready?
Chris Wade Unpacks the Gartner Hype Cycle for Life Sciences
When new technologies make bold promises, how do you discern the hype from what’s commercially viable? And when will such claims pay off, if at all? Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are potentially relevant to solving real business problems and exploiting…
Exeevo and Microsoft Talk Generative AI
Exeevo’s Chris Wade chats with George Corugedo, CTO and AI Strategist from Microsoft, about Microsoft’s vision for generative AI and how it will change how we work with tools in businesses. Microsoft has invested significantly in generative AI development to bring its capabilities into the market. One way Microsoft does this is through 365 Copilot,…
Crafting Successful Pharmaceutical HCP Marketing Tactics
HCP Marketing Tactics that Drive Digital Success The ever-evolving digital healthcare landscape has transformed how life sciences companies reach out to healthcare professionals (HCPs), making it crucial for pharmaceutical marketers to develop targeted HCP marketing tactics. With the rise of new digital technologies and communication channels, the traditional tactical marketing playbook is no longer enough…
Veeva and Salesforce Cancel their Partnership, Gartner Chimes In
Since the news broke that Veeva Systems has canceled its partnership with Salesforce, many Life Sciences CIOs have been left in the dark, wondering what this means for them, as this split presents a significant upheaval to their organizations. With uncertainty over migration, service agreements, or integrations, CIOs have limited time to assess the impact…
10 Reasons Life Sciences CIOS Need a Solution with a Native Teams Integration
Preparing for next-gen technology CIOs in the Life Sciences sector have more IT assets to manage than ever before. Many are looking to streamline their IT infrastructure and eliminate disparate SaaS solutions to prepare for a unified next-gen technology that can support business agility and fiscal prudence. Adopting a unified technology solution that provides flexibility,…
A Dialed-In Omnichannel Strategy Enhances Specialty Care CX
Pharma Must Use an Omnichannel Approach Across Multiple Platforms to Fully Engage HCPs In the wake of the pandemic, the relationship between pharmaceutical companies and specialty care providers evolved beyond the in-person relationship before COVID. Healthcare providers (HCPs) expect more than the traditional clinical information exchange and prefer to reach out in-person and online — and…
Bridging the Pharma Mindset Gap in Specialty Care CX
Overcome a Disconnect in HCP Engagement In our previous articles, we touched on how specialty care and the specialty care customer experience (CX) have changed in the post-COVID world. Pharma companies have more opportunities to reach providers overwhelmed with more patients and challenging cases through an omnichannel strategy and hybrid engagement. However, many companies struggle…
Continuing Specialty Care Digital Transformation
How Hybrid Engagement is Transforming Communication Between HCPs and Pharma As specialty care undergoes a digital transformation to meet medical staff and patients’ changing needs and priorities, pharma organizations must transform their engagement strategies to meet this shift. The initial excitement of digital communication channels during the height of COVID has started to wane as…